Gufic Biosciences Ltd - 509079 - Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2021
GUFIC BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2021 ,inter alia, to consider and approve Un-Audited Financial Results for the quarter and half year ended September 30, 2021 GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Credit Rating
Pursuant to Regulation 30 and other applicable provisions of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that M/s. CRISIL Ratings Limited, a credit rating agency, has rated the bank facilities availed by the Company, the details are enclosed herewith. Gufic Biosciences Ltd - 509079 - Shareholding for the Period Ended September 30, 2021
Gufic Biosciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here Gufic Biosciences Ltd - 509079 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ami N ShahDesignation :- Company Secretary and Compliance Officer GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018, Please find enclosed herewith the letter received from our Registrar and Share Transfer Agent, M/s Link Intime India Private Limited for the quarter ended September 30, 2021. Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Meeting Updates
Pursuant to Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 , we wish to inform you that the Board of Directors at their meeting held today i.e., October 04, 2021 has approved the proposal for increasing Capital Expenditure to the tune of Rs. 200 Crores out of which around Rs. 180 crores is proposed to be utilized for setting up of the Company's new manufacturing unit and balance Rs. 20 Crores for setting up the Research & Development facility, both in Indore, Madhya Pradesh. The details thereof are enclosed herewith. GUFIC BIOSCIENCES LTD. - 509079 - Closure of Trading Window
This is to inform you that pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the Company's Code of Practices & Procedure for Fair Disclosure and Code of Conduct to Regulate, Monitor and Report Trading in the Securities of the Company ('Code'), the trading window for trading in the shares of the Company will remain close from Friday, October 01, 2021 till 48 hours after the declaration of Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2021, for all the Designated Persons including their immediate relatives. The trading window will re-open after 48 hours from the announcement to the Stock Exchanges of the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2021. GUFIC BIOSCIENCES LTD. - 509079 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pravan J Choksi GUFIC BIOSCIENCES LTD. - 509079 - Revised disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jayesh P Chokse GUFIC BIOSCIENCES LTD. - 509079 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vipul J Choksi & PACs